Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Core EBITDA Margin

    Back to All Ratios
LASA SUPERGENERICS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results

LASA SUPERGENERICS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 2.13-5.0911.6823.3317.91

What is the latest Core EBITDA Margin ratio of LASA SUPERGENERICS ?

The latest Core EBITDA Margin ratio of LASA SUPERGENERICS is 2.13 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20242.13
Mar2023-5.09
Mar202211.68
Mar202123.33
Mar202017.91

How is Core EBITDA Margin of LASA SUPERGENERICS Trending?

Years Core EBITDA Margin % Change
Mar2024 2.13
Positive
Mar2023 -5.09
Negative
Mar2022 11.68
-49.94
Mar2021 23.33
30.26
Mar2020 17.91 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Core EBITDA Margin ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹43.1 Cr 1.8% -16.4% -69.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,622.0 Cr 2% -2.3% -12.6% Stock Analytics
DIVIS LABORATORIES ₹159,536.0 Cr -1.3% -6.2% 21.2% Stock Analytics
CIPLA ₹125,468.0 Cr -2.2% 3.6% -4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,162.0 Cr -0% -0.3% 5% Stock Analytics
DR REDDYS LABORATORIES ₹105,874.0 Cr -0.9% 4.5% -8.6% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

1.8%

-16.4%

-69.6%

SENSEX

1.1%

-0.4%

-2.2%


You may also like the below Video Courses